Global warming to continue, forecast for 2023 is hot
The world must brace for a possible El Nino next year, a climate pattern expected to drive up temperatures and trigger upheavals across
Climate
Health
Drugs
Pharma
US court dismisses antitrust claims against Dr. Reddy’s cancer drug
A US court dismissed all claims against Dr. Reddy's Laboratories Inc., a wholly-owned subsidiary, in an antitrust complaint related to the cancer drug
Climate
Health
Emergence of forests on Earth did not cut down CO2 levels in atmosphere, says study
A collaborative study found that the CO2 levels in Earth’s atmosphere were much lower than previously thought when forests emerged on our planet
Drugs
Medical
Pharma
China’s Everest starts first phase operations to make mRNA vaccines
Everest Medicines, a Chinese biopharmaceutical company, announced the start of operations in the first phase at a global manufacturing site to make an
Drugs
Medical
Pharma
83% of all Africans yet to receive a single Covid-19 vaccine dose
A third of the world’s population has still not received a single dose of the Covid-19 vaccine, including 83% of all Africans, according
Health
Medical
Researchers discover new treatment for diabetic retinopathy
Singapore researchers have found a new therapeutic target that can treat diabetes related blindness
Drugs
Pharma
Indian regulator approves Aurobindo Pharma drug for lung, brain infections
The Indian drug regulator had given its nod for Tergene, a joint venture of Aurobindo Pharma, to make a vaccine to fight pneumonia,
Drugs
Pharma
Advent to buy 50.1% stake in Suven Pharma for $762 million
Advent International, a global private equity investor, will buy a 50.1% stake in India’s Suven Pharmaceuticals for INR 63,130 million ($762 million), according
Health
Medical
Japanese research finds what triggers overeating
Research has shown that a particular gene—CREB- CREB-Regulated Transcription Coactivator 1 (CRTC1) is associated with obesity in humans.
Drugs
Medical
Pharma
Alembic gets USFDA nod for Fulvestrant to treat breast cancer
Alembic Pharma receives USFDA approval for breast cancer drug--Fulvestrant injection